Literature DB >> 7775477

The responsiveness of a tetracycline-sensitive expression system differs in different cell lines.

J R Howe1, B V Skryabin, S M Belcher, C A Zerillo, C Schmauss.   

Abstract

A tetracycline-sensitive inducible expression system was used to regulate the expression of neurotransmitter receptor genes in two mammalian cell lines. The dopamine D3-receptor was stably expressed in GH3 cells, and GluR6 (a glutamate receptor subunit) was stably expressed in human embryonic kidney (HEK 293) cells. Three striking differences were found. 1) In the inactive state, virtually no D3-receptor expression was found in GH3 cells, whereas substantial levels of GluR6 expression were found in HEK 293 cells. 2) The induction of expression obtained upon removal of tetracycline was robust in GH3 cells but only modest in HEK 293 cells. 3) Whereas in each clonal cell line, the expression of a co-transfected hybrid transactivator is clearly regulated in a tetracycline-responsive manner, in the induced state, its mRNA levels were found to be very low in GH3 cells and very high in HEK 293 cells. The results indicate that, in contrast to GH3 cells, HEK 293 cells do not provide a cellular environment in which the expression of a heterologous gene can be tightly controlled in a tetracycline-responsive manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775477     DOI: 10.1074/jbc.270.23.14168

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Conditional control of gene expression in the mammary gland.

Authors:  P A Furth
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Regulated gene expression in the chicken embryo by using replication-competent retroviral vectors.

Authors:  Noboru Sato; Kenji Matsuda; Chie Sakuma; Douglas N Foster; Ronald W Oppenheim; Hiroyuki Yaginuma
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Regulated gene expression in glioma cells: a comparison of three inducible systems.

Authors:  V Senner; A Sotoodeh; W Paulus
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

4.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop.

Authors:  J Woraratanadharm; S Rubinchik; H Yu; F Fan; S M Morrow; J Y Dong
Journal:  Gene Ther       Date:  2004-09       Impact factor: 5.250

6.  Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.

Authors:  Jiun-Shuan Chao; Chun-Chieh Chao; Chu-Li Chang; Yi-Rong Chiu; Chiun-Jye Yuan
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

Review 7.  Diverse strategies for tetracycline-regulated inducible gene expression.

Authors:  P E Shockett; D G Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.

Authors:  S T Chen; A Iida; L Guo; T Friedmann; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  High-affinity kainate-type ion channels in rat cerebellar granule cells.

Authors:  K E Pemberton; S M Belcher; J A Ripellino; J R Howe
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

10.  Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.

Authors:  B Massie; F Couture; L Lamoureux; D D Mosser; C Guilbault; P Jolicoeur; F Bélanger; Y Langelier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.